Bryson AE, Cabral HJ, Coles MS, et al. - Researchers conducted a retrospective chart review of patients receiving long-acting reversible contraception (LARC) (etonogestrel 68 mg implant, levonorgestrel 52 mg intrauterine device, or copper intrauterine device), with the aim to assess attendance of an initial follow-up visit after LARC insertion and determine if follow-up was linked with a higher likelihood of method continuation in adolescents and young adults (AYAs). Of 331 participants aged 13-28 years, nearly one-third (29.3%) attended a follow-up visit indicating attendence by only few AYAs in an initial follow-up visit after LARC placement. The likelihood of LARC removal was higher in the first year in correlation with follow-up visit. However, in long-term, this correlation was not evident.